| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.0042 | 1 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.0041 | 1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.00094 | 1 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.00023 | 1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0002 | 1 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.00011 | 1 |